Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease

Turkish Journal of Gastroenterology

Volumn 15, Issue 4, 2004, Pages 250-252

  Törüner, Murat ^a   Erkan, Özlem ^a   Soykan, Irfan ^a   Bozdayi, Mithat ^a   Çetinkaya, Hülya ^a   Yurdaydin, Cihan ^a   Uzunalimoǧlu, Özden ^a   Özden, Ali ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Factor V leiden; IBD; MTHFR; Prothrombin G20210A

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; PROTHROMBIN G20210A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; RISK; THROMBOEMBOLISM; THROMBOSIS; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FACTOR V; FEMALE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; PROTHROMBIN; TURKEY;

EID: 13244281692     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Talbot RW, Heppell J, Dozois RR, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61(2): 140-5.
2. Bernstein CN, Blanchard JF, Houston DS et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85(3): 430-4.
3. Grip O, Svensson PJ, Lindgren S. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 2000; 35(6): 619-23.
4. DeMaria AN. Relative risk of cardiovascular events in patients with rheumatoid arthritis. Am J Cardiol 2002; 89(6A): 33D-38D.
5. Gabrielli M, Santoliquido A, Gasbarrini G, et al. Latent coeliac disease, hyperhomocysteinemia and pulmonary thromboembolism: a close link? Thromb Haemost 2003; 89(1): 203-4.
6. Liebman HA, Kashani N, Sutherland D, et al. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterology 1998; 115(4): 830-4.
7. Wong T, Nightingale J, Winter M, et al. Spontaneous venous thrombosis in inflammatory bowel disease: relevance of factor V Leiden and the prothrombin gene mutation. J Thromb Haemost 2003; 1(6): 1326-8.
8. Kader HA, Berman WF, Al-Seraihy AS, et al. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002; 35(5): 629-35.
9. Vecchi M, Sacchi E, Saibeni S, et al. Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. Dig Dis Sci 2000; 45(7): 1465-9.
10. Turri D, Roselli M, Simioni P, et al. Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area. Dig Liver Dis 2001; 33(7): 559-62.
11. Arruda VR, von Zuben PM, Chiparini LC, et al. The mutation Ala677→Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997; 77(5): 818-21.
12. Ho CH. Prevalence of prothrombin 20210A allele and methylenetetrahydrofolate reductase C677T genetic mutations in the Chinese population. Ann Hematol 2000; 79(5): 239-42.
13. Antoniadi T, Hatzis T, Kroupis C, et al. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol 1999; 61(4): 265-7.
14. Canataroglu A, Tanriverdi K, Inal T, et al. Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behcet's disease. Rheumatol Int 2003; 23(5): 236-40.
15. Akar N, Misirlioglu M, Akar E, et al. Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol 1998; 58(3): 249.